WuXi AppTec

Undisclosed raised $29M on April 3, 2023

Investors: 博远资本, Lilly Asia Ventures, 中金公司, Qiming Venture Partners, Sequoia Capital China and WuXi AppTec

Structure Therapeutics raised $100M on October 20, 2021

Investors: TCG X, 泰福资本 TF Capital, Qiming Venture Partners, Surveyor Capital, Sequoia Capital China, Stork Capital S.à.r.l., Woodline Partners LP and WuXi AppTec

Undisclosed raised $188M on June 3, 2021

Investors: E Fund Management Co.,LTD., Forebright Capital, OrbiMed Advisors, CITIC Securities Company Limited, Tsing Capital, Sequoia Capital China and WuXi AppTec

Engine Biosciences raised $43M on May 26, 2021

Investors: Baidu.ventures, Polaris Partners, The Invus Group, EDBI Pte Ltd, Vectr Ventures, DHVC, WI Harper Group and WuXi AppTec

广州市基准医疗有限责任公司 raised $40M on February 22, 2021

Investors: OrbiMed Advisors and WuXi AppTec

Drug Farm Inc raised $56M on February 9, 2021

Investors: 浙江民营企业联合投资股份有限公司, BioVeda China Fund and WuXi AppTec

Undisclosed raised $200M on November 17, 2020

Investors: 经纬创投（北京）投资管理顾问有限公司, Temasek, Boyu Capital, Sequoia Capital China and WuXi AppTec

JW Therapeutics 药明巨诺 raised $100M on June 11, 2020

Investors: Mirae Asset MAPS Global Investments Co., Ltd, Temasek, Loyal Valley Capital, CITIC Private Equity Funds Management, ARCH Venture Partners, Sequoia Capital China, Juno Therapeutics, Inc. and WuXi AppTec

insitro raised $143M on May 26, 2020

Investors: Casdin Capital, LLC, GV, T. Rowe Price, Two Sigma Ventures, Foresite Capital, HOF Capital, Third Rock Ventures and WuXi AppTec

Immunocore raised $130M on March 2, 2020

Investors: JDRF T1D Fund, General Atlantic, RTW Investments, LP, Bill & Melinda Gates Foundation and WuXi AppTec